BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences

Rhea-AI Summary

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that CEO Jeffrey Bailey and CFO Terry Coelho will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, and the Cantor Fitzgerald Global Healthcare Conference from September 27-30. The H.C. Wainwright fireside chat will be available on-demand starting September 13 at 7:00 AM ET. The Cantor Fitzgerald presentation is scheduled for September 28 at 9:20 AM ET. Institutional investors can arrange one-on-one meetings with BDSI management through their sales representatives.

RALEIGH, N.C., Sept. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey, Chief Executive Officer, and Terry Coelho, Executive Vice President and Chief Financial Officer, will present and participate in one-on-one investor meetings at the H.C. Wainwright 23^rd Annual Global Investment Conference taking place on September 13-15 and the Cantor Fitzgerald Global Healthcare Conference taking place on September 27-30.

The fireside chat at the H.C. Wainwright 23^rd Annual Global Investment Conference will be available to conference registrants on-demand beginning Monday, September 13, 2021, at 7:00 AM ET.

Details for the live presentation at the Cantor Fitzgerald Global Healthcare Conference can be found below.

Date:	Tuesday, September 28, 2021
Time:	9:20 AM ET
Format:	Fireside chat
Webcast:	https://wsw.com/webcast/cantor12/bdsi/2064020

Institutional investors interested in a one-on-one meeting with BDSI management should contact their respective H.C. Wainwright or Cantor Fitzgerald institutional sales representative.

About BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

© 2021 BioDelivery Sciences International, Inc.  All rights reserved.

Contact:
Bob Yedid
LifeSci Advisors
646-597-6989
Bob@LifeSciAdvisors.com

FAQ

When will BioDelivery Sciences present at the H.C. Wainwright Conference?

BioDelivery Sciences will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021.

What time is BioDelivery Sciences' presentation at the Cantor Fitzgerald Conference?

BioDelivery Sciences' fireside chat at the Cantor Fitzgerald Global Healthcare Conference is scheduled for September 28, 2021, at 9:20 AM ET.

How can investors access the fireside chat from the H.C. Wainwright Conference?

The H.C. Wainwright fireside chat will be available on-demand starting September 13, 2021, at 7:00 AM ET.

What is the purpose of the investor meetings with BioDelivery Sciences management?

The investor meetings aim to provide institutional investors with insights into BioDelivery Sciences' operations and strategic direction.

Is there a webcast available for BioDelivery Sciences' presentation?

Yes, there is a webcast available for the Cantor Fitzgerald Global Healthcare Conference presentation, which can be accessed at the provided link.